Immunotherapy

Immunotherapy or biological therapy is the treatment of disease by activating or suppressing the immune system. Immunotherapies designed to elicit or amplify an immune response are classified as activation immunotherapies, while immunotherapies that reduce or suppress are classified as suppression immunotherapies. Immunotherapy is under preliminary research for its potential to treat various forms of cancer. Cell-based immunotherapies are effective for some cancers. Immune effector cells such as lymphocytes, macrophages, dendritic cells, natural killer cells, and cytotoxic T lymphocytes work together to defend the body against cancer by targeting abnormal antigens expressed on the surface of tumor cells. Vaccine-induced immunity to COVID-19 relies mostly on an immunomodulatory T cell response. Therapies such as granulocyte colony-stimulating factor, interferons, imiquimod and cellular membrane fractions from bacteria are licensed for medical use.

Read more in the app

Cancer biomarker data is not diverse, with implications for immunotherapy patients from underrepresented groups

Advanced melanoma survival improves significantly when immunotherapy is given before targeted therapy

Tumors form temporary structures to avoid immunotherapy treatments

Lupus Patients Go Into Remission in 'Spectacular' Immunotherapy Trial

Immunotherapy reduces lung and liver fibrosis in mice

Experimental test promises to predict side-effects and cancer's return in patients treated with immunotherapy

News at a glance: Immunotherapy for lupus, near-instant health effects of racism, and forest loss from mining

Tumor-infiltrating B cells and plasma cells influence early-stage lung cancer biology, immunotherapy responses

Immunotherapy drug did not increase surgery complications, study finds

More Effective Cancer Immunotherapy: Stanford’s New Method To Find Antigens That Trigger Specific Immune Cells

Researchers report encouraging immunotherapy option for relapsed myeloma patients

Giving immunotherapy cells resilience to pass the 'stress test'

Small Molecule Developed That Makes Immunotherapy Available to All Cancer Patients

Genetics may predict bladder cancer immunotherapy response

Destroying tumor cells: Targeted immunotherapy using injectable materials

Mathematical modeling to explain immunotherapy responses

Anti-rejection medication and immunotherapy kicks cancer and protects kidney transplants

A machine learning model to predict immunotherapy response in cancer patients

Whole exome sequencing predicts whether patients respond to cancer immunotherapy

Immunotherapy may get a boost